268 related articles for article (PubMed ID: 6842264)
1. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
Limburg PC; The TH; Hummel-Tappel E; Oosterhuis HJ
J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
[TBL] [Abstract][Full Text] [Related]
2. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine receptor antibodies in myasthenia gravis.
Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
[TBL] [Abstract][Full Text] [Related]
5. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
Kuks JB; Oosterhuis HJ; Limburg PC; The TH
J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
[TBL] [Abstract][Full Text] [Related]
6. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
7. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of thymoma in myasthenia gravis.
Aarli JA
Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
[TBL] [Abstract][Full Text] [Related]
9. Anti-acetylcholine receptor antibodies.
Vincent A; Newsom Davis J
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
[TBL] [Abstract][Full Text] [Related]
10. Frequency and features of myasthenia gravis developing after thymectomy.
Uzawa A; Kanai T; Oda F; Ozawa Y; Yasuda M; Kawaguchi N; Himuro K; Yoshino I; Kuwabara S
Eur J Neurol; 2020 Jan; 27(1):175-180. PubMed ID: 31347231
[TBL] [Abstract][Full Text] [Related]
11. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis with anti-acetylcholine receptor antibodies.
Meriggioli MN
Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
[TBL] [Abstract][Full Text] [Related]
13. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
Penn AS; Schotland DL; Lamme S
Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
[TBL] [Abstract][Full Text] [Related]
14. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6.
Mocchegiani E; Giacconi R; Muzzioli M; Gasparini N; Provinciali L; Spazzafumo L; Licastro F
Mech Ageing Dev; 2000 Aug; 117(1-3):79-91. PubMed ID: 10958925
[TBL] [Abstract][Full Text] [Related]
15. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
16. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
17. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
[TBL] [Abstract][Full Text] [Related]
18. Detection of thymoma in myasthenia gravis.
Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
[TBL] [Abstract][Full Text] [Related]
19. Heart muscle antibodies in myasthenia gravis.
Mygland A; Aarli JA; Hofstad H; Gilhus NE
Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]